Drug · DIN 02448319
TEVA-DEXTROAMPHETAMINE SR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 13, 2025; first marketed October 6, 2017.
- Drug Identification Number (DIN)
- 02448319
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Controlled drugs (cdsa i)
- Dosage form
- Capsule (Sustained-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Dexamfetamine N06BA02
- Class
- Human
- Record last updated
- October 30, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEXTROAMPHETAMINE SULFATE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 12, 2024: NOC 33058Supplement to a New Drug Submission (SNDS) · Administrative: Product Name Change. Update to the Product Monograph. Update to labels
- December 11, 2019: NOC 23006New Drug Submission (NDS) · Merger - buyout
- October 27, 2015: NOC 17424New Drug Submission (NDS)
Other DINs named TEVA-DEXTROAMPHETAMINE SR
- DIN 02448327 · Marketed